🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Concurrent Thoracic Radiation Therapy

Found 192 matching trials

Hypofractionated Radiotherapy Followed by Chemo-immunotherapy Induction Therapy

PHASE2

Radiotherapy can activate local and systemic immune responses through a var...

Status

Not Yet Recruiting

Location

Multiple Locations

Start Date

2025-04

Trial ID

NCT06914050

Treatments Being Tested

Adebrelimab EC/EP SBRT Chest radiotherapy

Surgery vs. Radical Chemoradiotherapy for Esophageal SCC After Neoadjuvant Immunochemotherapy

PHASE3

This is a Phase III, multicenter, open-label, randomized controlled trial. ...

Status

Recruiting

Location

Henan Cancer Hospital

Start Date

2026-06-16

Trial ID

NCT07629817

Treatments Being Tested

Toripalimab + Nab-paclitaxel + Platinum-based Chemotherapy Radiation with Concurrent Chemotherapy Radical Esophagectomy

A Multicenter, Open-label, Randomized, Prospective Clinical Study of Adebrelimab Consolidation Therapy for Limited-Stage Small-Cell Lung Cancer (LS-SCLC) Without Progression After Concurrent Chemoradiotherapy

PHASE2

This study aims to evaluate the efficacy and safety of adebrelimab consolid...

Status

Recruiting

Location

Henan Cancer Hospital

Start Date

2026-07-17

Trial ID

NCT07559786

Treatments Being Tested

CCRT(Employed residual field irradiation(RFI))CCRT(Involved-Field Radiotherapy (IFRT))

Safety Study of Nelfinavir + Cisplatin + Pelvic Radiation Therapy to Treat Cervical Cancer

PHASE1

Nelfinavir will increase the efficacy of Cisplatin based chemo- radiation t...

Status

Completed

Location

University of Miami

Start Date

2012-01

Trial ID

NCT01485731

Treatments Being Tested

Nelfinavir Cisplatin Pelvic External Beam Radiation Therapy Brachytherapy Pharmacokinetic Sampling Cervical Biopsy Pelvic Examination Pap Smear Audiogram Proctoscopy Cytoscopy Renal Ultrasound CT Scan Whole Body PET/CT Scan

A Study of Concurrent Chemoradiation With Atezolizumab in Participants With Untreated Extensive-Stage (ES) Small Cell Lung Cancer (SCLC)

PHASE2

Etoposide-cisplatin/ -carboplatin in combination with PD-L1 inhibitor for 4...

Status

Completed

Location

Hunan cancer hospital

Start Date

2020-06-01

Trial ID

NCT04636762

Treatments Being Tested

Radiation Therapy

Toxicity and Outcome of Whole Breast Hypofractionated Radiotherapy: a Single Institution Experience

N/A

This is a homogeneous, single institution, observational, non-interventiona...

Status

Active Not Recruiting

Location

IRCCS San Raffaele Scientific Institute

Start Date

2016-11-01

Trial ID

NCT03077191

Treatments Being Tested

Quality of life measurement

Efficacy and Safety of Albumin Paclitaxel Combined With Cisplatin Chemoradiotherapy for Non-resectable Stage III NSCLC

Non-resectable stage III non-small cell lung cancer is recommended for conc...

Status

Unknown

Location

Affiliated Hospital of Guizhou Medical University

Start Date

2019-09-01

Trial ID

NCT04284215

Treatments Being Tested

Albumin paclitaxel combined with cisplatin

Pre-operative Chemotherapy Versus Concurrent Chemoradiotherapy in N2 Positive IIIA Non Small Cell Lung Cancer (NSCLC)

PHASE2

It is suggested that a bimodal or trimodal approach combining neoadjuvant c...

Status

Unknown

Location

National Cancer Center, Korea

Start Date

2006-04

Trial ID

NCT00452803

Treatments Being Tested

chemotherapy Concurrent chemoradiation therapy Concurrent chemoradiation therapy

Chemoradiotherapy With or Without Enteral Nutrition for Locally Advanced Thoracic Esophageal Carcinoma

PHASE3

This is a randomized, prospective, multicenter study....

Status

Completed

Location

Sichuan Cancer Hospital & Institute

Start Date

2014-09

Trial ID

NCT02399306

Treatments Being Tested

Enteral nutrition radiotherapy

Placebo-controlled, Study of Concurrent Chemoradiation Therapy With Pembrolizumab Followed by Pembrolizumab and Olaparib in Newly Diagnosed Treatment-Naïve Limited-Stage Small Cell Lung Cancer (LS-SCLC) (MK 7339-013/KEYLYNK-013)

PHASE3

Researchers are looking for new ways to treat Limited-Stage Small Cell Lung...

Status

Active Not Recruiting

Location

Ironwood Cancer & Research Centers ( Site 0007)

Start Date

2020-12-08

Trial ID

NCT04624204

Treatments Being Tested

Pembrolizumab 200 mg Pembrolizumab 400 mg Pembrolizumab placebo (saline)Pembrolizumab placebo (saline)Olaparib 300 mg BID Olaparib matching placebo Etoposide 100 mg/m^2 Platinum, investigator's choice Standard Thoracic Radiotherapy Prophylactic Cranial Irradiation (PCI)

Previous Next